Skip to content
HowShorted

Relay Therapeutics, Inc. short interest in 2024

In 2024, Relay Therapeutics, Inc.'s disclosed short interest ran from 9.16% of shares outstanding on 12 Jan 2024 to 8.93% on 31 Dec 2024, a change of -0.23 percentage points. The year's high was 9.58% on 15 Mar 2024 and its low 6.07% on 28 Jun 2024, averaging 7.94% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 12.70 days on 12 Jan 2024. Full history: Relay Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Relay Therapeutics, Inc. in 2024

2024 in figures

Start of year
9.16% (12 Jan 2024)
End of year
8.93% (31 Dec 2024)
Change
-0.23 pp
High
9.58% (15 Mar 2024)
Low
6.07% (28 Jun 2024)
Average
7.94%
Highest days to cover
12.70 (12 Jan 2024)
SEC filings marked
8

Every report in 2024

Relay Therapeutics, Inc. short interest in 2024
SettlementShort interestDays to coverFilings since previous
12 Jan 20249.16%12.70
31 Jan 20247.67%10.49
15 Feb 20247.96%8.15
29 Feb 20248.92%9.4510-K filed, results (8-K)
15 Mar 20249.58%10.23
28 Mar 20249.06%8.73
15 Apr 20248.67%10.29
30 Apr 20248.68%8.06
15 May 20248.95%10.2710-Q filed, results (8-K)
31 May 20247.23%7.25
14 Jun 20247.42%6.77
28 Jun 20246.07%5.12
15 Jul 20246.35%6.09
31 Jul 20246.65%7.12
15 Aug 20246.76%9.6010-Q filed, results (8-K)
30 Aug 20246.77%12.61
13 Sep 20247.41%1.77
30 Sep 20249.24%6.16
15 Oct 20248.85%6.67
31 Oct 20249.00%10.52
15 Nov 20246.94%8.4710-Q filed, results (8-K)
29 Nov 20247.13%6.28
13 Dec 20247.22%3.75
31 Dec 20248.93%7.24

See also: Relay Therapeutics, Inc.'s full history · most shorted US stocks of 2024 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.